Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...

Cancer cases in Jammu and Kashmir have increased by 50 percent at Paras Health Srinagar from September 2023 to January 2025, ...

See "Use of Non-GAAP Financial Information". U.S. revenues increased 9% to $8.6 billion, primarily driven by higher demand for the Growth Portfolio and Eliquis, partially offset by the impact of ...

Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

Trust in AI is a crucial determinant of its integration into clinical practice. The study measured clinician trust levels and found a strong correlation between trust and agreement with AI ...